[STOK] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[STOK] Stoke Therapeutics, Inc.
Announcement Date
30-Dec-2018
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -29.09%
YoY-
Quarter Report
STOK's Result
STOK's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 2,802 3,269 0 0 0 0 -
PBT -26,958 -25,655 -24,448 -14,561 -10,160 -4,282 44.45%
Tax 10,714 -3,608 -78 -10 -904 0 -
NP -26,958 -22,047 -24,448 -14,561 -10,160 -4,282 44.45%
Tax Rate - - - - - - -
Total Cost 29,760 25,316 24,448 14,561 10,160 4,282 47.33%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -962.10 -674.43 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -0.60 -0.56 -0.66 -0.44 -0.31 -0.18 27.20%
EPS Diluted -0.60 -0.56 -0.66 -0.44 -0.31 -0.18 27.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.